Clinical Trials Directory

Trials / Completed

CompletedNCT06114342

The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls

The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls: A Prospective, Assessor-blinded, Comparative Study

Status
Completed
Phase
Study type
Observational
Enrollment
184 (actual)
Sponsor
Xiaomei Shao · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Evidence-based medicine suggests that acupuncture can improve major depressive disorder (MDD). However, the prevalent reliance on experiential acupoint selection lacks scientific underpinning. The investigators conducted a comparative study involving MDD patients and healthy subjects, employing modern techniques to discern biological specificity in MDD-related acupoints. Additionally, the investigators investigated potential correlations between acupoint biological specificity and MDD severity.

Detailed description

A final total of 134 eligible subjects were included. Among them, 50 healthy subjects were assigned to the healthy control (HC) group and 84 MDD participants were assigned to the MDD group.

Conditions

Timeline

Start date
2022-01-10
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2023-11-02
Last updated
2024-03-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06114342. Inclusion in this directory is not an endorsement.